Dirithromycin Impurities & Reference Standards

Invenza supplies high-quality Dirithromycin Reference Standards, Dirithromycin impurities, pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope-labeled compounds, and nitrosamine-related products for pharmaceutical research, analytical testing, and quality control applications.

Our Dirithromycin impurity reference standards are suitable for a wide range of pharmaceutical and analytical applications, including drug development, analytical method development and validation, quality control (QC), stability studies, impurity profiling, unknown impurity identification, regulatory submissions such as ANDA and DMF, and assessment of potential genotoxic impurities.

Dirithromycin-related reference standards are thoroughly characterized and supplied with Certificates of Analysis (COA) and supporting analytical data, subject to product availability and applicable specifications. We can also provide pharmacopeial and traceable reference standards, including EP/USP-related requirements, based on customer specifications

Our Dirithromycin impurity standards are manufactured, characterized, and handled to support reliable analytical testing and pharmaceutical research requirements. Products are periodically re-tested, where applicable, to help ensure consistent quality and dependable analytical performance.

CAT No. IR-A10219
CAS No. 62013-04-1
Molecular Formula C42H78N2O14
Molecular Weight 835.1
CAT No. IR-A10220
CAS No. 26116-56-3
Molecular Formula C37H70N2O12
Molecular Weight 735
CAT No. IR-A10221
CAS No. NA
Molecular Formula C29H56N2O9
Molecular Weight 576.8
CAT No. IR-A10222
CAS No. 141262-14-8
Molecular Formula C42H78N2O13
Molecular Weight 819.1
CAT No. IR-A10223
CAS No. 910914-82-8
Molecular Formula C41H76N2O14
Molecular Weight 821.1
CAT No. IR-A10224
CAS No. NA
Molecular Formula C40H74N2O12
Molecular Weight 775